NCT01842620View on ClinicalTrials.gov

OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck.

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

March 13, 2013

Primary Completion Date

May 4, 2013

Study Completion Date

May 4, 2013

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Metformin

Oral antidiabetic agent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01842620 - OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. | Biotech Hunter | Biotech Hunter